TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancer

Andersson ML, Böttiger Y, Lindh JD, Wettermark B, Eiermann B (2013) Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care. Eur J Clin Pharmacol 69(3):565–571. https://doi.org/10.1007/s00228-012-1338-y

Article  CAS  PubMed  Google Scholar 

Beinse G, Reitter D, Segaux L, Carvahlo-Verlinde M, Rousseau B, Tournigand C, Cudennec T, Laurent M, Boudou-Rouquette P, Paillaud E, Canouï-Poitrine F, Caillet P (2020) Potential drug-drug interactions and risk of unplanned hospitalization in older patients with cancer: a survey of the prospective ELCAPA (ELderly CAncer PAtients) cohort. J Geriatr Oncol 11(4):586–592. https://doi.org/10.1016/j.jgo.2019.07.023

Article  PubMed  Google Scholar 

Bennett F, Sofat R (2020) Polypharmacy: the whys, the so whats and the what nexts. Br J Hosp Med (lond) 81(5):1–7. https://doi.org/10.12968/hmed.2019.0383

Article  PubMed  Google Scholar 

Böttiger Y, Laine K, Andersson ML, Korhonen T, Molin B, Ovesjö ML, Tirkkonen T, Rane A, Gustafsson LL, Eiermann B (2009) SFINX-a drug-drug interaction database designed for clinical decision support systems. Eur J Clin Pharmacol 65(6):627–633. https://doi.org/10.1007/s00228-008-0612-5

Article  PubMed  Google Scholar 

Brokaar EJ, van den Bos F, Visser LE, Portielje JEA (2021) Deprescribing in older adults with cancer and limited life expectancy: an integrative review. Am J Hosp Palliat Care. https://doi.org/10.1177/10499091211003078

Article  PubMed  Google Scholar 

Castro-Manzanares M, Do Pazo-Oubiña F, Rodríguez-Rincón RM (2019) Prevalence of potential drug-drug interactions in outpatients on treatment with parenteral antineoplastic drugs. Int J Clin Pharm 41(6):1429–1433. https://doi.org/10.1007/s11096-019-00910-7

Article  CAS  PubMed  Google Scholar 

Chen LJ, Trares K, Laetsch DC, Nguyen TNM, Brenner H, Schöttker B (2020) Systematic review and meta-analysis on the associations of polypharmacy and potentially inappropriate medication with adverse outcomes in older cancer patients. J Gerontol A Biol Sci Med Sci. https://doi.org/10.1093/gerona/glaa128

Article  PubMed  PubMed Central  Google Scholar 

Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B (2020) Adverse outcomes of polypharmacy in older people: systematic review of reviews. J Am Med Dir Assoc 21(2):181–187. https://doi.org/10.1016/j.jamda.2019.10.022

Article  PubMed  Google Scholar 

de Agustín Sierra L, Rodríguez Salazar J, Jiménez-Muñoz AB, Molina Hernández MJ, Bermejo Bescós P, Iglesias Peinado I, García Díaz B (2021) Potentially inappropriate medication in acute hospitalized elderly patients with polypharmacy: an observational study comparing PRISCUS, STOPP, and Beers criteria. Eur J Clin Pharmacol 77(5):757–766. https://doi.org/10.1007/s00228-020-03022-8

Article  PubMed  Google Scholar 

Drenth-van Maanen AC, Leendertse AJ, Jansen PAF, Knol W, Keijsers C, Meulendijk MC, van Marum RJ (2018) The systematic tool to reduce inappropriate prescribing (STRIP): combining implicit and explicit prescribing tools to improve appropriate prescribing. J Eval Clin Pract 24(2):317–322. https://doi.org/10.1111/jep.12787

Article  PubMed  Google Scholar 

Garfinkel D, Zur-Gil S, Ben-Israel J (2007) The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 9(6):430–434

PubMed  Google Scholar 

Haider S, Descallar J, Moylan E, Chua W (2020) Polypharmacy and the use of low or limited value medications in advanced cancer. Intern Med J. https://doi.org/10.1111/imj.14964

Article  Google Scholar 

Hakozaki T, Hosomi Y, Shimizu A, Kitadai R, Mirokuji K, Okuma Y (2020) Polypharmacy as a prognostic factor in older patients with advanced non-small-cell lung cancer treated with anti-PD-1/PD-L1 antibody-based immunotherapy. J Cancer Res Clin Oncol 146(10):2659–2668. https://doi.org/10.1007/s00432-020-03252-4

Article  CAS  PubMed  Google Scholar 

Hakozaki T, Matsuo T, Shimizu A, Ishihara Y, Hosomi Y (2021) Polypharmacy among older advanced lung cancer patients taking EGFR tyrosine kinase inhibitors. J Geriatr Oncol 12(1):64–71. https://doi.org/10.1016/j.jgo.2020.09.011

Article  CAS  PubMed  Google Scholar 

Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, Cohen HJ, Feussner JR (1992) A method for assessing drug therapy appropriateness. J Clin Epidemiol 45(10):1045–1051

Article  CAS  PubMed  Google Scholar 

Hill-Taylor B, Walsh KA, Stewart S, Hayden J, Byrne S, Sketris IS (2016) Effectiveness of the STOPP/START (screening tool of older persons’ potentially inappropriate prescriptions/screening tool to alert doctors to the right treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther 41(2):158–169. https://doi.org/10.1111/jcpt.12372

Article  CAS  PubMed  Google Scholar 

Hoemme A, Barth H, Haschke M, Krähenbühl S, Strasser F, Lehner C, von Kameke A, Wälti T, Thürlimann B, Früh M, Driessen C, Joerger M (2019) Prognostic impact of polypharmacy and drug interactions in patients with advanced cancer. Cancer Chemother Pharmacol 83(4):763–774. https://doi.org/10.1007/s00280-019-03783-9

Article  PubMed  Google Scholar 

Hong S, Lee JH, Chun EK, Kim KI, Kim JW, Kim SH, Lee YG, Hwang IG, Kim JY, Koh SJ, Ko YH, Shin SH, Woo IS, Kim TY, Baek JY, Kim HJ, Kim HJ, Lee MA, Kwon JH, Hong YS, Ryoo HM, Kim JH (2020) Polypharmacy, inappropriate medication use, and drug interactions in older Korean patients with cancer receiving first-line palliative chemotherapy. Oncologist 25(3):e502–e511. https://doi.org/10.1634/theoncologist.2019-0085

Article  CAS  PubMed  Google Scholar 

Ismail M, Khan S, Khan F, Noor S, Sajid H, Yar S, Rasheed I (2020) Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy. BMC Cancer 20(1):335. https://doi.org/10.1186/s12885-020-06855-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karuturi MS, Holmes HM, Lei X, Johnson M, Barcenas CH, Cantor SB, Gallick GE, Bast RC, Giordano SH (2019) Potentially inappropriate medications defined by STOPP criteria in older patients with breast and colorectal cancer. J Geriatr Oncol 10(5):705–708. https://doi.org/10.1016/j.jgo.2019.01.024

Article  PubMed  PubMed Central  Google Scholar 

Kotlinska-Lemieszek A, Paulsen O, Kaasa S, Klepstad P (2014) Polypharmacy in patients with advanced cancer and pain: a European cross-sectional study of 2282 patients. J Pain Symptom Manage 48(6):1145–1159. https://doi.org/10.1016/j.jpainsymman.2014.03.008

Article  PubMed  Google Scholar 

Lau DT, Kasper JD, Potter DE, Lyles A, Bennett RG (2005) Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 165(1):68–74. https://doi.org/10.1001/archinte.165.1.68

Article  PubMed  Google Scholar 

Lavan AH, O’Mahony D, O’Mahony D, Gallagher P (2021) Potentially inappropriate medication (PIM) use and severe drug interactions (SDIs) in older adults with cancer. J Geriatr Oncol. https://doi.org/10.1016/j.jgo.2021.02.021

Article  PubMed  Google Scholar 

Lawlor PG, Bush SH (2015) Delirium in patients with cancer: assessment, impact, mechanisms and management. Nat Rev Clin Oncol 12(2):77–92. https://doi.org/10.1038/nrclinonc.2014.147

Article  PubMed  Google Scholar 

Lindsay J, Dooley M, Martin J, Fay M, Kearney A, Khatun M, Barras M (2015) The development and evaluation of an oncological palliative care deprescribing guideline: the “OncPal deprescribing guideline.” Support Care Cancer 23(1):71–78. https://doi.org/10.1007/s00520-014-2322-0

Article  PubMed  Google Scholar 

Lu-Yao G, Nightingale G, Nikita N, Keith S, Gandhi K, Swartz K, Zinner R, Sharma S, Kelly WMK, Chapman A (2020) Relationship between polypharmacy and inpatient hospitalization among older adults with cancer treated with intravenous chemotherapy. J Geriatr Oncol 11(4):579–585. https://doi.org/10.1016/j.jgo.2020.03.001

Article  PubMed  PubMed Central  Google Scholar 

Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE (2017) What is polypharmacy? A systematic review of definitions. BMC Geriatr 17(1):230. https://doi.org/10.1186/s12877-017-0621-2

Article  PubMed  PubMed Central  Google Scholar 

Midão L, Giardini A, Menditto E, Kardas P, Costa E (2018) Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch Gerontol Geriatr 78:213–220. https://doi.org/10.1016/j.archger.2018.06.018

Article  PubMed  Google Scholar 

Mohamed MR, Ramsdale E, Loh KP, Arastu A, Xu H, Obrecht S, Castillo D, Sharma M, Holmes HM, Nightingale G, Juba KM, Mohile SG (2020) Associations of polypharmacy and inappropriate medications with adverse outcomes in older adults with cancer: a systematic review and meta-analysis. Oncologist 25(1):e94–e108. https://doi.org/10.1634/theoncologist.2019-0406

Article  PubMed  Google Scholar 

Niehoff KM, Mecca MC, Fried TR (2019) Medication appropriateness criteria for older adults: a narrative review of criteria and supporting studies. Ther Adv Drug Saf 10:2042098618815431. https://doi.org/10.1177/2042098618815431

Article  PubMed  PubMed Central  Google Scholar 

Nightingale G, Pizzi LT, Barlow A, Barlow B, Jacisin T, McGuire M, Swartz K, Chapman A (2018) The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software. J Geriatr Oncol 9(5):526–533. https://doi.org/10.1016/j.jgo.2018.02.001

Article  PubMed  Google Scholar 

Payne RA (2016) The epidemiology of polypharmacy. Clin Med (lond) 16(5):465–469. https://doi.org/10.7861/clinmedicine.16-5-465

Article  PubMed  Google Scholar 

Prely H, Herledan C, Caffin AG, Baudouin A, Larbre V, Maire M, Schwiertz V, Vantard N, Ranchon F, Rioufol C (2021) Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases. J Cancer Res Clin Oncol. https://doi.org/10.1007/s00432-021-03645-z

Article  PubMed  Google Scholar 

Ramasubbu SK, Mahato SK, Agnihotri A, Pasricha RK, Nath UK, Das BD (2021) Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: a prospective study in a tertiary care teaching hospital. Cancer Treat Res Commun 26:100277. https://doi.org/10.1016/j.ctarc.2020.100277

Article  PubMed  Google Scholar 

Ramsdale E, Mohamed M, Yu V, Otto E, Juba K, Awad H, Moorthi K, Plumb S, Patil A, Vogelzang N, Dib E, Mohile S (2022) Polypharmacy, potentially inappropriate medications, and drug-drug interactions in vulnerable older adults with advanced cancer initiating cancer treatment. Oncologist 27(7):e580–e588. https://doi.org/10.1093/oncolo/oyac053

Article  PubMed 

留言 (0)

沒有登入
gif